A rapidly growing body of evidence suggests that MRI-guidance can reduce radiation-treatment-related toxicity by more than 50% as compared to conventional CT guided treatments.
Published last week in leading oncology journal Nature Reviews Clinical Oncology, our researchers have collaborated on an important and timely resource for oncologists. The invited paper Integrated MRI-guided radiation therapy: Opportunities and challenges comes at a time when a new technology, MRI-guided radiation therapy (MRIgRT) is rapidly shifting the field of cancer radiation therapy. Led by Institute Director Professor Paul Keall, this high profile review brought together international research leaders from Europe, the USA and Australia.
“MRI-Linacs are new cancer treatment systems that have integrated an MRI scanner and linear accelerator, are rapidly being clinically deployed: however the opportunity for outcome improvements comes with the challenges of added complexity and cost.” says Professor Keall.
In addition to Prof Keall, five researchers from Image X contributed to the work; Brendan Whelan, Caterina Brighi, David Waddington, Shanshan Shan and Paul Liu.
Read the paper Integrated MRI-guided radiation therapy: Opportunities and challenges for free here: https://rdcu.be/cLF8T